28247308|t|Differential Maturation of miR-17 ~ 92 Cluster Members in Human Cancer Cell Lines
28247308|a|While some microRNAs are transcribed from a specific promoter, at least one third of human miRNA genes are clustered, wherein multiple miRNA genes are generated from a single primary transcript such as miR-17 ~ 92 cluster. Although six members of the cluster are generated from a single transcript, the mature level of each member may be diverse in various cell types. Here, we attempt to monitor the mature level of miR-17, miR-92a, and miR-20a from miR-17 ~ 92 cluster in blood (HL60 (human promyelocytic leukemia cells) and Jurkat) and breast (MDA-MB-231 and MCF-7) cancer cell lines. Interestingly, different mature levels of the miRNAs were observed in each cell line. While miR-20 was highly matured in HL60 and MDA-iMB-231 cell lines, higher mature level of miR-92a was observed in Jurkat cell line compared to that of miR-20 and miR-17. Further, the mature level of miRNAs was also measured in normal and cancer cell lines. Although the mature level of miR-17 and miR-92a increased in HL60 and Jurkat cell lines, miR-20 expression showed an almost identical level in blood cancer cell lines compared to controls. Conversely, miR-20 mature level significantly increased in breast cancer cell lines whereas the expression level of miR-92a was comparable in MDA-MB-231, MCF-7, and MCF-10A cell lines.
28247308	0	12	Differential	T080	C0443199
28247308	13	23	Maturation	T045	C1158729
28247308	27	38	miR-17 ~ 92	T028	C1537713
28247308	39	46	Cluster	T028	C0017258
28247308	47	54	Members	T098	C0680022
28247308	58	63	Human	T016	C0086418
28247308	64	81	Cancer Cell Lines	T025	C0334227
28247308	93	102	microRNAs	T114,T123	C1101610
28247308	107	118	transcribed	T045	C0040649
28247308	126	143	specific promoter	T114,T123	C0086860
28247308	167	172	human	T016	C0086418
28247308	173	184	miRNA genes	T028	C2825314
28247308	189	198	clustered	T028	C0017258
28247308	217	228	miRNA genes	T028	C2825314
28247308	250	275	single primary transcript	T114,T123	C1136155
28247308	284	303	miR-17 ~ 92 cluster	T028	C1537713
28247308	333	340	cluster	T028	C0017258
28247308	362	379	single transcript	T114	C1519595
28247308	385	391	mature	T079	C0205286
28247308	392	397	level	T080	C0441889
28247308	439	449	cell types	T170	C0449475
28247308	460	467	attempt	T062	C3166483
28247308	483	489	mature	T045	C1158729
28247308	490	495	level	T080	C0441889
28247308	499	505	miR-17	T028	C1537713
28247308	507	514	miR-92a	T028	C1537748
28247308	520	527	miR-20a	T028	C1825998
28247308	533	544	miR-17 ~ 92	T028	C1537713
28247308	545	552	cluster	T028	C0017258
28247308	556	561	blood	T031	C0005767
28247308	563	567	HL60	T025	C1512310
28247308	569	574	human	T016	C0086418
28247308	575	597	promyelocytic leukemia	T191	C2745900
28247308	598	603	cells	T025	C0007634
28247308	609	615	Jurkat	T025	C0376448
28247308	621	627	breast	T023	C0006141
28247308	629	639	MDA-MB-231	T025	C0007634
28247308	644	649	MCF-7	T025	C0596890
28247308	651	668	cancer cell lines	T025	C0334227
28247308	695	701	mature	T045	C1158729
28247308	702	708	levels	T080	C0441889
28247308	716	722	miRNAs	T114,T123	C1101610
28247308	728	736	observed	T169	C1441672
28247308	745	754	cell line	T025	C0007634
28247308	762	768	miR-20	T028	C1825998
28247308	780	787	matured	T045	C1158729
28247308	791	795	HL60	T025	C1512310
28247308	800	811	MDA-iMB-231	T025	C0007634
28247308	812	822	cell lines	T025	C0007634
28247308	831	837	mature	T045	C1158729
28247308	838	843	level	T080	C0441889
28247308	847	854	miR-92a	T028	C1537748
28247308	859	867	observed	T169	C1441672
28247308	871	887	Jurkat cell line	T025	C0376448
28247308	888	896	compared	T052	C1707455
28247308	908	914	miR-20	T028	C1825998
28247308	919	925	miR-17	T028	C1537713
28247308	940	946	mature	T079	C0205286
28247308	947	952	level	T080	C0441889
28247308	956	962	miRNAs	T114,T123	C1101610
28247308	972	980	measured	T080	C0444706
28247308	995	1012	cancer cell lines	T025	C0334227
28247308	1027	1033	mature	T079	C0205286
28247308	1034	1039	level	T080	C0441889
28247308	1043	1049	miR-17	T028	C1537713
28247308	1054	1061	miR-92a	T028	C1537748
28247308	1062	1071	increased	T081	C0205217
28247308	1075	1079	HL60	T025	C1512310
28247308	1084	1101	Jurkat cell lines	T025	C0376448
28247308	1103	1109	miR-20	T028	C1825998
28247308	1110	1120	expression	T045	C0017262
28247308	1138	1147	identical	T080	C0205280
28247308	1148	1153	level	T080	C0441889
28247308	1157	1180	blood cancer cell lines	T025	C0334227
28247308	1181	1189	compared	T052	C1707455
28247308	1193	1201	controls	T080	C0243148
28247308	1215	1221	miR-20	T028	C1825998
28247308	1222	1228	mature	T079	C0205286
28247308	1229	1234	level	T080	C0441889
28247308	1235	1258	significantly increased	T081	C4055637
28247308	1262	1286	breast cancer cell lines	T025	C1512505
28247308	1299	1309	expression	T045	C0017262
28247308	1310	1315	level	T080	C0441889
28247308	1319	1326	miR-92a	T028	C1537748
28247308	1345	1355	MDA-MB-231	T025	C0007634
28247308	1357	1362	MCF-7	T025	C0596890
28247308	1368	1375	MCF-10A	T025	C0007634
28247308	1376	1386	cell lines	T025	C0007634